How to Source Non-IMP Supplies for Clinical Trials
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to...
Trending menu:
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to...
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP supplies for clinical trials
Hedley Rees, Chief Disruptor, PharmaFlow, discusses the need for a rethink on supply chain processes
Francesco Spoto, Clinical Project Manager, explores the opportunities of using IRT solutions to manage blinded information in clinical trials
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations in Asia
Barrett Glasser, Associate Director, Clinical Drug Supply, Biogen, provides an overview on how to on board newly acquired therapeutic assets
For the past ten years, the industry has seen an increased demand to determine fair market value of CRO and other clinical trial service providers.
Ian Hoban, Pilatus Comparator Solutions, poses some key questions that should be front of mind and considered early on in the design of your clinical trial
Peter Shapiro, Editor-In-Chief, PharmSource, a GlobalData Product, assesses key trends currently changing the face of the contract manufacturing industry
Jesper Franke, Head of Healthcare, GS1 Denmark, explains how the industry can best improve supply chain processes by adopting industry standards
Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics, offers insight on how to create efficiencies within the clinical supply chain
Go Top